Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report

Antagonists of tumour necrosis factor α (TNFα) are a common therapeutic choice for autoimmune diseases. Although they are effective and relatively safe, an increasing number of immune-mediated adverse events have been reported. Among these, neurological adverse effectsm such as consisting of demyeli...

Descripción completa

Detalles Bibliográficos
Autores principales: Iovino, Aniello, Aruta, Francesco, Dubbioso, Raffaele, Ruggiero, Lucia, Tozza, Stefano, Spina, Emanuele, Manganelli, Fiore, Iodice, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755935/
https://www.ncbi.nlm.nih.gov/pubmed/33424233
http://dx.doi.org/10.1177/1179573520973820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755935/
https://www.ncbi.nlm.nih.gov/pubmed/33424233
http://dx.doi.org/10.1177/1179573520973820

Ejemplares similares